FAGR — Fagron NV Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareBalancedMid CapHigh Flyer
- €1.23bn
- €1.51bn
- €683.88m
- 80
- 35
- 79
- 73
Annual cashflow statement for Fagron NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 54.8 | 69.9 | 73.7 | 76.8 | 87.8 |
| Non-Cash Items | 38.1 | 23.1 | 47.7 | 42.9 | 41.3 |
| Discontinued Operations | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -19.7 | -15.9 | -28.5 | -41.3 | -19.6 |
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 73.3 | 77.2 | 93 | 78.4 | 109 |
| Capital Expenditures | -15.7 | -22.2 | -18.4 | -20.7 | -18.5 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -38.9 | -21.4 | -32.9 | -11.2 | -50.8 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -54.6 | -43.6 | -51.3 | -31.9 | -69.3 |
| Financing Cash Flow Items | -18.4 | -14.9 | -14.6 | -13.8 | -11.9 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.79 | -4.49 | -53.1 | -61.6 | 13.9 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 16.8 | 29.1 | -22.4 | -13.6 | 54.7 |